EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Fertoz Limited (FTZZF) fair value: what the stock is really worth

We calculate from audited financials what Fertoz Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Sep 17, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Basic Materials · US

FL Fertoz Limited logo Thin data Sep 17, 2026

Fertoz Limited

FTZZF · US

Weak valuationQuality is weak on top of the rich price.

!Fair value $0.0061 · Overvalued (−12.9%)
!Quality 25/100
!Weak Growth (revenue 5y +8.0 %/yr)
!Loss-making · -85.2% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (3/10)
!Narrow moat 3/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 16 out of 100
Watch Fertoz Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.0694 $0.0004 Fair Value $0.0061 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 17, 2026.

How to read this chart

60‑month range $0.0004 – $0.0694 · the $0.0070 price screens above the $0.0061 fair value. Dashed = 300-day average. As of Sep 17, 2026.

Follow Fertoz in your weekly email

Every Wednesday you see whether Fertoz is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Canadian Phosphate Limited supplies regenerative phosphate and organic fertilizers products in Australia and North America. The company holds interests in two rock phosphate mining projects, comprising the Wapiti project comprising an area of approximately 78 km²; and Fernie projects that covers an area of approximately 108 km² in British Columbia, Canada.

Show more

Canadian Phosphate Limited supplies regenerative phosphate and organic fertilizers products in Australia and North America. The company holds interests in two rock phosphate mining projects, comprising the Wapiti project comprising an area of approximately 78 km²; and Fernie projects that covers an area of approximately 108 km² in British Columbia, Canada. It also offers fused calcium magnesium silica phosphate products. The company was formerly known as Fertoz Limited and changed its name to Canadian Phosphate Limited in February 2025. Canadian Phosphate Limited was incorporated in 2010 and is based in Perth, Australia.

Stock analysis

Fertoz Limited (FTZZF) currently trades at $0.0070, while our model-based Fair Value estimate is $0.0061, 12.9% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Quality & growth

The Quality Score stands at 25/100 (below-average quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Fertoz Limited reported revenue of A$2.3M in FY2025 versus A$2.2M in FY2021, a compound +0.7%/yr. Reported net income was −A$2.2M in FY2025.

Key figures

Market cap $2.8M · P/S ratio 0.99 · EPS (TTM) $−0.0100 · Net margin −95.8% · Return on equity −30.1% · Return on assets (EBIT) −22.2% · Operating margin −77.8% · Revenue (TTM) A$2.4M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and at its 52-week low, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at 15% fair-value upside, at −13%, FTZZF screens richer than that median.

Fair Value models

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $0.0100 $0.0100 $0.0200 52
All 1 models by family
Asset-Based
NCAV (Graham) $0.0100 $0.0100 $0.0200 52

Open the full fair value analysis →

Notify me when FTZZF reaches fair value

Put FTZZF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 25/100

Of which business quality 27 · Market factors (momentum, volatility) 73

Profitability 1
Margins and returns on capital today
Quality Growth 14
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 69
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 42
Calm price path (market factor)
Momentum 78
Price trend over the last 3–12 months (market factor)
52W Momentum 100
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 24/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−7.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.0%
Start year 2020 (pandemic). Over 10 years: +22.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+103.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−78.8% (2020) → −62.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

FTZZF screens overvalued: fair value 13% below the price. Compare with Corteva, Inc →

Compare Fertoz Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 178 stocks

Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 25 · Bottom 25%
Fair Value upside −12.9% · Below median
Profitability
Return on assets −15.7% · Bottom 25%
Net margin (TTM) −85.2% · Bottom 25%
Operating margin (TTM) −77.8% · Bottom 25%
Growth and dividend
Revenue growth 193.0% · Top 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Agricultural Inputs median · lower = cheaper

P/B 0.31× · Cheapest 25%
P/S (TTM) 1.13× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)16 · sector 20
FUTURE (revenue growth)100 · sector 32
PAST (return on equity)0 · sector 24
HEALTH (low debt)98 · sector 97
DIVIDEND (yield)0 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $78.52 $28.63 −64%
Nutrien Ltd NTR $72.23 $83.09 +15%
Qinghai Salt Lake Industry Co 000792 ¥23.70 ¥26.81 +13%
CF Industries Holdings CF $115.51 $163.44 +41%
SABIC Agri-Nutrients Company 2020 123.60 SAR 150.65 SAR +22%
Yara International ASA YAR kr 433.10 kr 662.97 +53%
Yunnan Yuntianhua Co 600096 ¥27.56 ¥50.49 +83%
The Mosaic Company MOS $23.01 $25.77 +12%
ICL Group ICL $5.14 $2.98 −42%
Coromandel International Limited COROMANDEL ₹1,964 ₹1,129 −43%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Fertoz Limited · Fair Value
$0.0061 −13%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Fertoz Limited Fair Value". https://www.fairvalue-calculator.com/stock/FTZZF

Frequently asked questions

Is Fertoz Limited (FTZZF) overvalued or undervalued?
As of Sep 17, 2026, our model estimates a fair value of $0.0061 versus a price of $0.0070, about −13% upside (overvalued).
What is the fair value of FTZZF?
Our model-based fair value for Fertoz Limited is $0.0061 (as of Sep 17, 2026), built from audited fundamentals. The current price: $0.0070.
What is the quality score of FTZZF?
Fertoz Limited has a Quality Score of 25/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Fertoz Limited (FTZZF)?
Our model-based price target is the fair value of $0.0061 (as of Sep 17, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Fertoz Limited stock forecast for 2026?
Our models put fair value at $0.0061, about −13% upside versus a price of $0.0070 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Fertoz Limited (FTZZF)?
Fertoz Limited reported trailing-twelve-month revenue of about A$2.4M (latest available figure, as of Sep 17, 2026).
What is the intrinsic value of Fertoz Limited (FTZZF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Fertoz Limited it is $0.0061 per share (as of Sep 17, 2026), against a price of $0.0070. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Fertoz Limited stock overvalued or undervalued in 2026?
As of Sep 17, 2026, FTZZF trades above its calculated fair value: price $0.0070, fair value $0.0061, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FTZZF?
No. The price is what the market pays today ($0.0070); the fair value is what the company's own numbers justify ($0.0061). For Fertoz Limited the two are $0.0009 per share apart. That gap is exactly why we show both numbers side by side.
How much is Fertoz Limited worth?
The market values Fertoz Limited at about $2.8M (market capitalisation, as of Sep 17, 2026). Per share that is $0.0070; our models calculate a fair value of $0.0061 per share.
How solid is the balance sheet of Fertoz Limited (FTZZF)?
Balance-sheet figures for Fertoz Limited (as of Sep 17, 2026): return on equity −30.1%, debt of 0.03 per unit of equity. They feed the Quality Score of 25/100, which measures business quality independently of the share price.
How far is FTZZF from its 52-week high?
Fertoz Limited trades at $0.0070, at its 52-week high of $0.0070 and at the low of $0.0070 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0061 is for.
Which stocks are comparable to Fertoz Limited?
From the same area (Basic Materials) we also value Corteva, Inc, Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Fertoz Limited stock attractive at the current price?
The data as of Sep 17, 2026: price $0.0070, calculated fair value $0.0061 (−13%), Quality Score 25/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FTZZF calculated?
We run Fertoz Limited through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0061, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Fertoz Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Fertoz Limited (FTZZF)?
The closing price on Sep 25, 2026 was $0.0070. Our model-based fair value is $0.0061, about −13% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Fertoz Limited right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of Fertoz Limited

How large is the market capitalisation of Fertoz Limited (FTZZF)?
The market capitalisation of Fertoz Limited is $2.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Fertoz Limited (FTZZF)?
The price-to-sales ratio of Fertoz Limited is 0.99 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Fertoz Limited (FTZZF)?
Earnings per share at Fertoz Limited are $−0.0100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Fertoz Limited (FTZZF)?
The net margin of Fertoz Limited is −95.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Fertoz Limited (FTZZF)?
The return on equity (ROE) of Fertoz Limited is −30.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Fertoz Limited (FTZZF)?
On an EBIT basis the return on assets of Fertoz Limited is −22.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Fertoz Limited (FTZZF)?
The operating margin of Fertoz Limited is −77.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Fertoz Limited (FTZZF)?
Revenue at Fertoz Limited is growing +193% versus a year earlier (3y avg −13.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Fertoz Limited (FTZZF) generate?
The free cash flow of Fertoz Limited is −A$506K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Fertoz Limited (FTZZF) hold?
Fertoz Limited holds more cash than debt, A$1.1M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Fertoz Limited in the live analysis

One click puts Fertoz Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.